Literature DB >> 9335089

Computed tomography of hereditary multifocal renal cystadenocarcinomas in German shepherd dogs.

L Moe1, B Lium.   

Abstract

The purpose of the study was to characterize the renal lesions of hereditary renal cystadenocarcinomas in the German shepherd dog using computed tomography (CT). Fourteen dogs with renal cystadenocarcinomas and nodular dermatofibrosis, and two unaffected dogs were studied. There were nine dogs with spontaneous disease and seven dogs from a test mating. The characteristic renal CT findings of renal cystadenocarcinomas were bilateral multiple cysts and tumor masses of various sizes. The earliest changes were detected between 4 and 5 years of age and the smallest cysts measured 2-3 mm in diameter. Abdominal CT examination gives a wide field view and excellent anatomic images of the kidneys. It is easy to differentiate between cysts and solid tumors. CT examination is useful for the early detection of renal cystadenocarcinomas and for screening suspected carrier dogs before breeding.

Entities:  

Mesh:

Year:  1997        PMID: 9335089     DOI: 10.1111/j.1740-8261.1997.tb02094.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  3 in total

1.  Loss of heterozygosity at the FLCN locus in early renal cystic lesions in dogs with renal cystadenocarcinoma and nodular dermatofibrosis.

Authors:  Tina B Bønsdorff; Johan H Jansen; Ragnar F Thomassen; Frode Lingaas
Journal:  Mamm Genome       Date:  2009-04-23       Impact factor: 2.957

2.  Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs.

Authors:  T J Jónasdóttir; C S Mellersh; L Moe; R Heggebø; H Gamlem; E A Ostrander; F Lingaas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Contrast-enhanced computed tomography findings of canine primary renal tumors including renal cell carcinoma, lymphoma, and hemangiosarcoma.

Authors:  Toshiyuki Tanaka; Hideo Akiyoshi; Hidetaka Nishida; Keiichiro Mie; Lee-Shuan Lin; Yasumasa Iimori; Mari Okamoto
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.